Back
Catalyst Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Buy
57
CPRX
Catalyst Pharmaceuticals
Last Price:
21.95
Seasonality Move:
-2.02%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Catalyst Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.76 | Buy |
| 20-day SMA: | 21.21 | Buy |
| 50-day SMA: | 20.55 | Buy |
| 200-day SMA: | 17.06 | Buy |
| 8-day EMA: | 21.72 | Buy |
| 20-day EMA: | 21.3 | Buy |
| 50-day EMA: | 20.45 | Buy |
| 200-day EMA: | 17.72 | Buy |
Catalyst Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 63.99 | Buy |
| Chaikin Money Flow: | 627083 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (20.18 - 21.74) | Buy |
| Bollinger Bands (100): | (16.55 - 21.01) | Buy |
Catalyst Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Catalyst Pharmaceuticals Stock
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 21.96 while CPRX 8-day simple moving average is 21.76, which is a Buy signal.
- The stock price of CPRX is 21.96 while Catalyst Pharmaceuticals 20-day SMA is 21.21, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day simple moving average is 20.55 while CPRX share price is 21.96, making it a Buy technically.
- CPRX stock price is 21.96 and Catalyst Pharmaceuticals 200-day simple moving average is 17.06, creating a Buy signal.
CPRX Technical Analysis vs Fundamental Analysis
Buy
57
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy or a Sell?
-
Catalyst Pharmaceuticals stock is rated a Buy
The current Catalyst Pharmaceuticals [CPRX] share price is $21.96. The Score for CPRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Catalyst Pharmaceuticals Stock Info
Market Cap:
2.61B
Price in USD:
21.96
Share Volume:
872.46K
Catalyst Pharmaceuticals 52-Week Range
52-Week High:
22.27
52-Week Low:
12.27
Buy
57
Catalyst Pharmaceuticals (CPRX)
is a Buy
Catalyst Pharmaceuticals Share Price Forecast
-
What is the Catalyst Pharmaceuticals stock price today?
The Catalyst Pharmaceuticals stock price is 21.96 USD today. -
Will CPRX stock go up or go down?
Catalyst Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Catalyst Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Catalyst Pharmaceuticals is not overvalued.
Is Catalyst Pharmaceuticals Stock a Buy?
- Catalyst Pharmaceuticals share price is 21.96 while CPRX 8-day exponential moving average is 21.72, which is a Buy signal.
- The stock price of CPRX is 21.96 while Catalyst Pharmaceuticals 20-day EMA is 21.30, which makes it a Buy.
- Catalyst Pharmaceuticals 50-day exponential moving average is 20.45 while CPRX share price is 21.96, making it a Buy technically.
- CPRX stock price is 21.96 and Catalyst Pharmaceuticals 200-day simple moving average is 17.72, creating a Buy signal.
Fundamental Analysis of Catalyst Pharmaceuticals
Is Catalyst Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Technical Analysis of Catalyst Pharmaceuticals
Should I short Catalyst Pharmaceuticals stock?
- CPRX Moving Average Covergence Divergence (MACD) indicator is 0.46, suggesting Catalyst Pharmaceuticals is a Buy
- Catalyst Pharmaceuticals Relative Strength Index (RSI) is 63.99, which suggest Catalyst Pharmaceuticals is overbought
- The Bollinger Bands (25) for Catalyst Pharmaceuticals is (20.18 - 21.74), which suggest Catalyst Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Catalyst Pharmaceuticals is (16.55 - 21.01), which suggest Catalyst Pharmaceuticals is a Buy
* Catalyst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.